

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 7.93275367 |
| 2 | regulation of response to osmotic stress (GO:0047484) | 7.92422102 |
| 3 | positive regulation of cellular amide metabolic process (GO:0034250) | 7.88032391 |
| 4 | keratinization (GO:0031424) | 7.87940578 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.19076073 |
| 6 | cytidine metabolic process (GO:0046087) | 6.93136182 |
| 7 | cytidine catabolic process (GO:0006216) | 6.93136182 |
| 8 | cytidine deamination (GO:0009972) | 6.93136182 |
| 9 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.68103346 |
| 10 | somite rostral/caudal axis specification (GO:0032525) | 6.51665335 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.43762022 |
| 12 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.95644838 |
| 13 | muscle organ morphogenesis (GO:0048644) | 5.94836106 |
| 14 | coenzyme catabolic process (GO:0009109) | 5.81657246 |
| 15 | negative regulation of epidermis development (GO:0045683) | 5.54896820 |
| 16 | response to dietary excess (GO:0002021) | 5.48973315 |
| 17 | maintenance of protein location in nucleus (GO:0051457) | 5.24488976 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 5.19198268 |
| 19 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.11442153 |
| 20 | protein localization to kinetochore (GO:0034501) | 5.11352815 |
| 21 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 5.00707412 |
| 22 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.97589875 |
| 23 | hormone catabolic process (GO:0042447) | 4.92080015 |
| 24 | quinone metabolic process (GO:1901661) | 4.89877348 |
| 25 | interferon-gamma production (GO:0032609) | 4.87004926 |
| 26 | nucleoside transmembrane transport (GO:1901642) | 4.83017539 |
| 27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.75849977 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.72184897 |
| 29 | regulation of cellular amide metabolic process (GO:0034248) | 4.63021613 |
| 30 | positive regulation of humoral immune response (GO:0002922) | 4.61372022 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51458674 |
| 32 | microglial cell activation (GO:0001774) | 4.48507514 |
| 33 | notochord development (GO:0030903) | 4.46720874 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.44353257 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 4.42891643 |
| 36 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.38020483 |
| 37 | phenol-containing compound catabolic process (GO:0019336) | 4.35760001 |
| 38 | regulation of cilium movement (GO:0003352) | 4.34748007 |
| 39 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.33430380 |
| 40 | omega-hydroxylase P450 pathway (GO:0097267) | 4.30969616 |
| 41 | * regulation of MHC class I biosynthetic process (GO:0045343) | 4.23502766 |
| 42 | neutrophil mediated immunity (GO:0002446) | 4.22218440 |
| 43 | establishment of skin barrier (GO:0061436) | 4.21513444 |
| 44 | negative regulation of telomerase activity (GO:0051974) | 4.18442705 |
| 45 | regulation of G0 to G1 transition (GO:0070316) | 4.03279734 |
| 46 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.97937750 |
| 47 | icosanoid secretion (GO:0032309) | 3.97366818 |
| 48 | arachidonic acid secretion (GO:0050482) | 3.97366818 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96952007 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.96952007 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96952007 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.96952007 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96952007 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96952007 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.95811910 |
| 56 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.95231454 |
| 57 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.94919815 |
| 58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.94637035 |
| 59 | negative regulation of interleukin-17 production (GO:0032700) | 3.93957136 |
| 60 | keratinocyte proliferation (GO:0043616) | 3.91727625 |
| 61 | dendritic cell migration (GO:0036336) | 3.91586194 |
| 62 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.88556036 |
| 63 | rRNA transcription (GO:0009303) | 3.88144671 |
| 64 | ventricular system development (GO:0021591) | 3.82149947 |
| 65 | phenylpropanoid metabolic process (GO:0009698) | 3.81992134 |
| 66 | detection of external biotic stimulus (GO:0098581) | 3.80638558 |
| 67 | myeloid leukocyte mediated immunity (GO:0002444) | 3.80456335 |
| 68 | regulation of translation in response to stress (GO:0043555) | 3.77849095 |
| 69 | protein K11-linked deubiquitination (GO:0035871) | 3.74379696 |
| 70 | iron ion import (GO:0097286) | 3.74093254 |
| 71 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.70013954 |
| 72 | thyroid hormone generation (GO:0006590) | 3.69384950 |
| 73 | nucleoside transport (GO:0015858) | 3.66880504 |
| 74 | primitive streak formation (GO:0090009) | 3.66227130 |
| 75 | histone H4-K5 acetylation (GO:0043981) | 3.63060251 |
| 76 | histone H4-K8 acetylation (GO:0043982) | 3.63060251 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 3.62952115 |
| 78 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.60425561 |
| 79 | detection of other organism (GO:0098543) | 3.59547529 |
| 80 | macrophage activation (GO:0042116) | 3.58801142 |
| 81 | negative regulation of telomere maintenance (GO:0032205) | 3.57780238 |
| 82 | rRNA methylation (GO:0031167) | 3.57715442 |
| 83 | cellular response to ethanol (GO:0071361) | 3.56809129 |
| 84 | establishment of endothelial barrier (GO:0061028) | 3.54978191 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.51635556 |
| 86 | cofactor transport (GO:0051181) | 3.50984355 |
| 87 | transepithelial transport (GO:0070633) | 3.50417960 |
| 88 | mitochondrion distribution (GO:0048311) | 3.49760096 |
| 89 | xenobiotic catabolic process (GO:0042178) | 3.48853004 |
| 90 | regulation of water loss via skin (GO:0033561) | 3.44872803 |
| 91 | hepatocyte apoptotic process (GO:0097284) | 3.35986013 |
| 92 | histone H4-K12 acetylation (GO:0043983) | 3.35794990 |
| 93 | histone mRNA catabolic process (GO:0071044) | 3.34237954 |
| 94 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.32008109 |
| 95 | cellular extravasation (GO:0045123) | 3.31032337 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.31031448 |
| 97 | intestinal epithelial cell development (GO:0060576) | 3.30049678 |
| 98 | bone trabecula formation (GO:0060346) | 3.29282644 |
| 99 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.29249730 |
| 100 | histone H3-K36 demethylation (GO:0070544) | 3.28111445 |
| 101 | detection of biotic stimulus (GO:0009595) | 3.27638553 |
| 102 | chromatin assembly (GO:0031497) | 3.26796208 |
| 103 | trophectodermal cell differentiation (GO:0001829) | 3.25900716 |
| 104 | cofactor catabolic process (GO:0051187) | 3.25076628 |
| 105 | protein localization to chromosome, centromeric region (GO:0071459) | 3.23541061 |
| 106 | icosanoid transport (GO:0071715) | 3.23413025 |
| 107 | fatty acid derivative transport (GO:1901571) | 3.23413025 |
| 108 | cullin deneddylation (GO:0010388) | 3.21803998 |
| 109 | hypotonic response (GO:0006971) | 3.20873834 |
| 110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.20402302 |
| 111 | protein K48-linked deubiquitination (GO:0071108) | 3.19156479 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 3.18245370 |
| 113 | dosage compensation (GO:0007549) | 3.16977088 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 3.16785558 |
| 115 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.16729328 |
| 116 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.16308841 |
| 117 | defense response to Gram-negative bacterium (GO:0050829) | 3.16000805 |
| 118 | rRNA modification (GO:0000154) | 3.15858681 |
| 119 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.12979650 |
| 120 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12141928 |
| 121 | negative regulation of cell killing (GO:0031342) | 3.11907033 |
| 122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11907033 |
| 123 | negative regulation of interleukin-12 production (GO:0032695) | 3.11738461 |
| 124 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.11509812 |
| 125 | regulation of beta-amyloid formation (GO:1902003) | 3.11397385 |
| 126 | hair cycle (GO:0042633) | 3.09609761 |
| 127 | molting cycle (GO:0042303) | 3.09609761 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07735433 |
| 129 | positive regulation of macrophage cytokine production (GO:0060907) | 3.07294514 |
| 130 | histone H3-K4 trimethylation (GO:0080182) | 3.06235686 |
| 131 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.05518908 |
| 132 | L-ascorbic acid metabolic process (GO:0019852) | 3.04657520 |
| 133 | mitotic sister chromatid segregation (GO:0000070) | 3.03781584 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01593813 |
| 135 | biotin metabolic process (GO:0006768) | 3.00475829 |
| 136 | early endosome to late endosome transport (GO:0045022) | 3.00350551 |
| 137 | DNA replication checkpoint (GO:0000076) | 2.99950962 |
| 138 | cell-substrate junction assembly (GO:0007044) | 2.99750260 |
| 139 | Rap protein signal transduction (GO:0032486) | 2.98635564 |
| 140 | negative regulation of B cell proliferation (GO:0030889) | 2.97442535 |
| 141 | desmosome organization (GO:0002934) | 2.96581540 |
| 142 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.96128863 |
| 143 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.94400365 |
| 144 | vitamin A metabolic process (GO:0006776) | 2.93003141 |
| 145 | response to peptidoglycan (GO:0032494) | 2.92362313 |
| 146 | response to host immune response (GO:0052572) | 2.92017134 |
| 147 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92017134 |
| 148 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89639596 |
| 149 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.89402641 |
| 150 | protein deneddylation (GO:0000338) | 2.88394178 |
| 151 | trabecula morphogenesis (GO:0061383) | 2.87345360 |
| 152 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87067849 |
| 153 | cyclooxygenase pathway (GO:0019371) | 2.86635623 |
| 154 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.86504452 |
| 155 | mitotic G2/M transition checkpoint (GO:0044818) | 2.85559767 |
| 156 | heterochromatin organization (GO:0070828) | 2.84747088 |
| 157 | thyroid hormone metabolic process (GO:0042403) | 2.84130817 |
| 158 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.83348795 |
| 159 | embryonic process involved in female pregnancy (GO:0060136) | 2.82999397 |
| 160 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.81451284 |
| 161 | negative regulation of complement activation (GO:0045916) | 2.80610520 |
| 162 | B cell receptor signaling pathway (GO:0050853) | 2.80399796 |
| 163 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80021205 |
| 164 | detection of temperature stimulus (GO:0016048) | 2.79150072 |
| 165 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.77806111 |
| 166 | nuclear pore complex assembly (GO:0051292) | 2.76898509 |
| 167 | maintenance of protein localization in organelle (GO:0072595) | 2.76811037 |
| 168 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.76614701 |
| 169 | protein K63-linked deubiquitination (GO:0070536) | 2.76133697 |
| 170 | necroptotic process (GO:0070266) | 2.75796500 |
| 171 | detection of bacterium (GO:0016045) | 2.75494627 |
| 172 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.74936985 |
| 173 | response to host (GO:0075136) | 2.71838292 |
| 174 | response to host defenses (GO:0052200) | 2.71838292 |
| 175 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71838292 |
| 176 | nuclear pore organization (GO:0006999) | 2.71593541 |
| 177 | pore complex assembly (GO:0046931) | 2.69440002 |
| 178 | regulation of necroptotic process (GO:0060544) | 2.69418286 |
| 179 | keratinocyte differentiation (GO:0030216) | 2.68756310 |
| 180 | import into cell (GO:0098657) | 2.68289680 |
| 181 | positive regulation of p38MAPK cascade (GO:1900745) | 2.68082943 |
| 182 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64952668 |
| 183 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.64678295 |
| 184 | negative regulation of B cell mediated immunity (GO:0002713) | 2.64678295 |
| 185 | necrotic cell death (GO:0070265) | 2.64296291 |
| 186 | response to muramyl dipeptide (GO:0032495) | 2.63215539 |
| 187 | myeloid cell activation involved in immune response (GO:0002275) | 2.61777487 |
| 188 | regulation of interleukin-8 secretion (GO:2000482) | 2.60392809 |
| 189 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.59733957 |
| 190 | defense response to fungus (GO:0050832) | 2.56519124 |
| 191 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.53496025 |
| 192 | regulation of fibroblast apoptotic process (GO:2000269) | 2.50837025 |
| 193 | polyketide metabolic process (GO:0030638) | 11.3435279 |
| 194 | doxorubicin metabolic process (GO:0044598) | 11.3435279 |
| 195 | daunorubicin metabolic process (GO:0044597) | 11.3435279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.92034696 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.82798211 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.82798211 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.82798211 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.50884381 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.89856901 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.57886866 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.56096754 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.39377075 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.37062599 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.00759279 |
| 12 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.89673155 |
| 13 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.87325048 |
| 14 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.80798837 |
| 15 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.74718827 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.72027808 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69722629 |
| 18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.65151016 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63438000 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.41056789 |
| 21 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.35421495 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.34946187 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.34485463 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27690548 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26102240 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22436864 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21867268 |
| 28 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.21693505 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16661822 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.10391099 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09129575 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07732779 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07264339 |
| 34 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.94914783 |
| 35 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93082302 |
| 36 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.92203643 |
| 37 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.92203643 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.86433251 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86194220 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84890796 |
| 41 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.82844208 |
| 42 | TP53_16413492_ChIP-PET_HCT116_Human | 1.82058011 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81882414 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81848665 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81574814 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79445720 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.77976326 |
| 48 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.77703093 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.76557017 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73602906 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69594201 |
| 52 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.68978460 |
| 53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.68143589 |
| 54 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.65960415 |
| 55 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.60870238 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.60229123 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58632332 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56038959 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53309201 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50277403 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42037365 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42034814 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40478334 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40400831 |
| 65 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.40377813 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.40207930 |
| 67 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.40047278 |
| 68 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38422820 |
| 69 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36404026 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35821019 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35212846 |
| 72 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34149336 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32819612 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31858934 |
| 75 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.31097531 |
| 76 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.30371067 |
| 77 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30341359 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30066291 |
| 79 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30024672 |
| 80 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.28622613 |
| 81 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27748442 |
| 82 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.26488306 |
| 83 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.25201638 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24786570 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24260623 |
| 86 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23968782 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23698708 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23061952 |
| 89 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.22876611 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21754967 |
| 91 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.21117314 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20736844 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20185193 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19977363 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18894178 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18349108 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17835116 |
| 98 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.16818717 |
| 99 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15455520 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14853652 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14089674 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13216320 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11112605 |
| 104 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10715262 |
| 105 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09352027 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08245909 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08179807 |
| 108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07958823 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07449696 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.07306331 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06840049 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06122603 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06103011 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05983956 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05600196 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05540296 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04970827 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04970827 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04933376 |
| 120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04920975 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04705813 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04393210 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04269599 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03698560 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03409367 |
| 126 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02993602 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02792706 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02090604 |
| 129 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01689085 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01226880 |
| 131 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01111147 |
| 132 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01109027 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00905331 |
| 134 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00476543 |
| 135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00394487 |
| 136 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00371007 |
| 137 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99517186 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99252304 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98647705 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98220867 |
| 141 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98031389 |
| 142 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98031389 |
| 143 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97891416 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97702581 |
| 145 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97628911 |
| 146 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.96667927 |
| 147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96665487 |
| 148 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96318672 |
| 149 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95127470 |
| 150 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94859402 |
| 151 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94659219 |
| 152 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.88684066 |
| 153 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86851452 |
| 154 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.83045975 |
| 155 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.81938092 |
| 156 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.81751564 |
| 157 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81706047 |
| 158 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.79145579 |
| 159 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.78905700 |
| 160 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78787607 |
| 161 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.76019306 |
| 162 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.72452964 |
| 163 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.71206627 |
| 164 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.70993210 |
| 165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.70893598 |
| 166 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68388534 |
| 167 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.68190742 |
| 168 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.67635461 |
| 169 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67158704 |
| 170 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66733635 |
| 171 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.66375827 |
| 172 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.66124704 |
| 173 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.66029380 |
| 174 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.65123038 |
| 175 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64872143 |
| 176 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.63774727 |
| 177 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.62807261 |
| 178 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.62505306 |
| 179 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61444606 |
| 180 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.61276463 |
| 181 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60056879 |
| 182 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.59812187 |
| 183 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.59195583 |
| 184 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59077949 |
| 185 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.59071956 |
| 186 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.57764875 |
| 187 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.54894486 |
| 188 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.53967396 |
| 189 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53895363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.79672998 |
| 2 | MP0003011_delayed_dark_adaptation | 4.56604135 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.34144145 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 4.07619395 |
| 5 | MP0005499_abnormal_olfactory_system | 3.91862234 |
| 6 | MP0005394_taste/olfaction_phenotype | 3.91862234 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.78993000 |
| 8 | MP0004858_abnormal_nervous_system | 3.71158892 |
| 9 | MP0006292_abnormal_olfactory_placode | 3.36276139 |
| 10 | MP0008260_abnormal_autophagy | 3.26828218 |
| 11 | MP0002332_abnormal_exercise_endurance | 3.21675489 |
| 12 | MP0000579_abnormal_nail_morphology | 3.18583640 |
| 13 | MP0003122_maternal_imprinting | 3.00224860 |
| 14 | MP0005409_darkened_coat_color | 2.96538063 |
| 15 | MP0006082_CNS_inflammation | 2.94866591 |
| 16 | MP0002796_impaired_skin_barrier | 2.90062727 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.80682081 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.79625391 |
| 19 | MP0002254_reproductive_system_inflammat | 2.79281019 |
| 20 | MP0005275_abnormal_skin_tensile | 2.73856403 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.72189222 |
| 22 | MP0003724_increased_susceptibility_to | 2.54803345 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.47677333 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 2.46330123 |
| 25 | MP0005257_abnormal_intraocular_pressure | 2.45255371 |
| 26 | MP0000015_abnormal_ear_pigmentation | 2.27187840 |
| 27 | MP0005174_abnormal_tail_pigmentation | 2.19868435 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.15545689 |
| 29 | MP0000762_abnormal_tongue_morphology | 2.02252104 |
| 30 | MP0002060_abnormal_skin_morphology | 1.99324854 |
| 31 | MP0008057_abnormal_DNA_replication | 1.96491979 |
| 32 | MP0004947_skin_inflammation | 1.94621583 |
| 33 | MP0003121_genomic_imprinting | 1.94157784 |
| 34 | MP0001216_abnormal_epidermal_layer | 1.85830294 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.84075041 |
| 36 | MP0003941_abnormal_skin_development | 1.79056059 |
| 37 | MP0004957_abnormal_blastocyst_morpholog | 1.77114575 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75132394 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.74697405 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.69481726 |
| 41 | MP0002132_abnormal_respiratory_system | 1.68906683 |
| 42 | MP0008789_abnormal_olfactory_epithelium | 1.67728537 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.67106912 |
| 44 | MP0003787_abnormal_imprinting | 1.64538834 |
| 45 | MP0004043_abnormal_pH_regulation | 1.62202393 |
| 46 | MP0000049_abnormal_middle_ear | 1.60055798 |
| 47 | MP0005451_abnormal_body_composition | 1.60032306 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.57339327 |
| 49 | MP0003303_peritoneal_inflammation | 1.57041415 |
| 50 | MP0005501_abnormal_skin_physiology | 1.55216009 |
| 51 | MP0005266_abnormal_metabolism | 1.53298468 |
| 52 | MP0002127_abnormal_cardiovascular_syste | 1.52516260 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.49708207 |
| 54 | MP0003938_abnormal_ear_development | 1.49015456 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.45629101 |
| 56 | MP0001800_abnormal_humoral_immune | 1.43241835 |
| 57 | MP0002233_abnormal_nose_morphology | 1.41878526 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.40965485 |
| 59 | MP0005380_embryogenesis_phenotype | 1.40965485 |
| 60 | MP0003690_abnormal_glial_cell | 1.40851698 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 1.36974805 |
| 62 | MP0010771_integument_phenotype | 1.36741588 |
| 63 | MP0002932_abnormal_joint_morphology | 1.35720667 |
| 64 | MP0003984_embryonic_growth_retardation | 1.34652808 |
| 65 | MP0002419_abnormal_innate_immunity | 1.32359044 |
| 66 | MP0004381_abnormal_hair_follicle | 1.32228700 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.29746020 |
| 68 | MP0003755_abnormal_palate_morphology | 1.28626297 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.27429987 |
| 70 | MP0002006_tumorigenesis | 1.26547455 |
| 71 | MP0003186_abnormal_redox_activity | 1.26478855 |
| 72 | MP0000427_abnormal_hair_cycle | 1.23942163 |
| 73 | MP0001851_eye_inflammation | 1.23352430 |
| 74 | MP0005508_abnormal_skeleton_morphology | 1.16400079 |
| 75 | MP0002009_preneoplasia | 1.16221599 |
| 76 | MP0000749_muscle_degeneration | 1.16050041 |
| 77 | MP0009785_altered_susceptibility_to | 1.15628926 |
| 78 | MP0005025_abnormal_response_to | 1.15042155 |
| 79 | MP0002452_abnormal_antigen_presenting | 1.14852268 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.12541430 |
| 81 | MP0002723_abnormal_immune_serum | 1.12202725 |
| 82 | MP0005464_abnormal_platelet_physiology | 1.12189809 |
| 83 | MP0000685_abnormal_immune_system | 1.11815272 |
| 84 | MP0000467_abnormal_esophagus_morphology | 1.10618544 |
| 85 | MP0005000_abnormal_immune_tolerance | 1.08108126 |
| 86 | MP0002396_abnormal_hematopoietic_system | 1.06961176 |
| 87 | MP0002653_abnormal_ependyma_morphology | 1.05824395 |
| 88 | MP0002114_abnormal_axial_skeleton | 1.05725542 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.05066742 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.03214020 |
| 91 | MP0000432_abnormal_head_morphology | 1.02484521 |
| 92 | MP0002095_abnormal_skin_pigmentation | 1.02073745 |
| 93 | MP0002405_respiratory_system_inflammati | 1.01740918 |
| 94 | MP0001819_abnormal_immune_cell | 1.00833203 |
| 95 | MP0008961_abnormal_basal_metabolism | 1.00645169 |
| 96 | MP0001191_abnormal_skin_condition | 1.00392345 |
| 97 | MP0001849_ear_inflammation | 0.99946119 |
| 98 | MP0001293_anophthalmia | 0.99332516 |
| 99 | MP0000858_altered_metastatic_potential | 0.99038212 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.98184717 |
| 101 | MP0000371_diluted_coat_color | 0.96778533 |
| 102 | MP0003937_abnormal_limbs/digits/tail_de | 0.96700889 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.95945963 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94462653 |
| 105 | MP0002092_abnormal_eye_morphology | 0.93214707 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.92921795 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.92067281 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.91831793 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.91419266 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.91419266 |
| 111 | MP0002398_abnormal_bone_marrow | 0.91004429 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.90906320 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.89599735 |
| 114 | MP0003935_abnormal_craniofacial_develop | 0.89083220 |
| 115 | MP0006054_spinal_hemorrhage | 0.88530286 |
| 116 | MP0004484_altered_response_of | 0.86508045 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.86191545 |
| 118 | MP0000716_abnormal_immune_system | 0.86039770 |
| 119 | MP0005023_abnormal_wound_healing | 0.85326269 |
| 120 | MP0005164_abnormal_response_to | 0.84011846 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.83937315 |
| 122 | MP0004130_abnormal_muscle_cell | 0.83682278 |
| 123 | MP0000920_abnormal_myelination | 0.83386592 |
| 124 | MP0000367_abnormal_coat/_hair | 0.82974039 |
| 125 | MP0005310_abnormal_salivary_gland | 0.82577036 |
| 126 | MP0003828_pulmonary_edema | 0.82198251 |
| 127 | MP0002722_abnormal_immune_system | 0.81484778 |
| 128 | MP0003448_altered_tumor_morphology | 0.81279426 |
| 129 | MP0009931_abnormal_skin_appearance | 0.79122795 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.78898670 |
| 131 | MP0010307_abnormal_tumor_latency | 0.78422800 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.76624573 |
| 133 | MP0004883_abnormal_blood_vessel | 0.76426497 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.76084194 |
| 135 | MP0002116_abnormal_craniofacial_bone | 0.76073421 |
| 136 | MP0003329_amyloid_beta_deposits | 0.76042869 |
| 137 | MP0000604_amyloidosis | 0.75756501 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.74790192 |
| 139 | MP0003632_abnormal_nervous_system | 0.74335721 |
| 140 | MP0003646_muscle_fatigue | 0.74106391 |
| 141 | MP0003123_paternal_imprinting | 0.73608693 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.73264916 |
| 143 | MP0005621_abnormal_cell_physiology | 0.72908238 |
| 144 | MP0009764_decreased_sensitivity_to | 0.71598334 |
| 145 | MP0003077_abnormal_cell_cycle | 0.71531569 |
| 146 | MP0000428_abnormal_craniofacial_morphol | 0.71092898 |
| 147 | MP0002925_abnormal_cardiovascular_devel | 0.70434789 |
| 148 | MP0000689_abnormal_spleen_morphology | 0.70156223 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.69963626 |
| 150 | MP0000377_abnormal_hair_follicle | 0.68298819 |
| 151 | MP0001915_intracranial_hemorrhage | 0.67821667 |
| 152 | MP0003936_abnormal_reproductive_system | 0.67453279 |
| 153 | MP0003436_decreased_susceptibility_to | 0.66439774 |
| 154 | MP0008872_abnormal_physiological_respon | 0.66062162 |
| 155 | MP0004272_abnormal_basement_membrane | 0.65903522 |
| 156 | MP0004134_abnormal_chest_morphology | 0.64375037 |
| 157 | MP0003566_abnormal_cell_adhesion | 0.63687736 |
| 158 | MP0005319_abnormal_enzyme/_coenzyme | 0.63411100 |
| 159 | MP0001286_abnormal_eye_development | 0.63274336 |
| 160 | MP0004197_abnormal_fetal_growth/weight/ | 0.62130363 |
| 161 | MP0003091_abnormal_cell_migration | 0.61321965 |
| 162 | MP0003453_abnormal_keratinocyte_physiol | 0.61279552 |
| 163 | MP0001790_abnormal_immune_system | 0.60076913 |
| 164 | MP0005387_immune_system_phenotype | 0.60076913 |
| 165 | MP0001905_abnormal_dopamine_level | 0.59697969 |
| 166 | MP0008770_decreased_survivor_rate | 0.58279519 |
| 167 | MP0000383_abnormal_hair_follicle | 0.56470618 |
| 168 | MP0010678_abnormal_skin_adnexa | 0.56416357 |
| 169 | MP0008775_abnormal_heart_ventricle | 0.56241200 |
| 170 | MP0000343_altered_response_to | 0.55446436 |
| 171 | MP0006036_abnormal_mitochondrial_physio | 0.55031109 |
| 172 | MP0005390_skeleton_phenotype | 0.53721726 |
| 173 | MP0009703_decreased_birth_body | 0.53451670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Onycholysis (HP:0001806) | 6.98611380 |
| 2 | Bilateral microphthalmos (HP:0007633) | 6.88713075 |
| 3 | Milia (HP:0001056) | 6.71666270 |
| 4 | Abnormality of nail color (HP:0100643) | 6.44338656 |
| 5 | Plantar hyperkeratosis (HP:0007556) | 5.80162654 |
| 6 | Fragile nails (HP:0001808) | 5.76066014 |
| 7 | Thick nail (HP:0001805) | 5.10364350 |
| 8 | Hepatoblastoma (HP:0002884) | 4.95747283 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 4.75479915 |
| 10 | Rib fusion (HP:0000902) | 4.56361346 |
| 11 | Atrophic scars (HP:0001075) | 4.37827530 |
| 12 | Palmoplantar hyperkeratosis (HP:0000972) | 4.31012907 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.19739220 |
| 14 | Multiple enchondromatosis (HP:0005701) | 4.18587105 |
| 15 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.17364975 |
| 16 | Palmar hyperkeratosis (HP:0010765) | 4.11309842 |
| 17 | Rectal fistula (HP:0100590) | 3.93158146 |
| 18 | Rectovaginal fistula (HP:0000143) | 3.93158146 |
| 19 | T lymphocytopenia (HP:0005403) | 3.66203672 |
| 20 | Partial duplication of thumb phalanx (HP:0009944) | 3.64659027 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.60790293 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.56440860 |
| 23 | Intestinal fistula (HP:0100819) | 3.49766289 |
| 24 | Fused cervical vertebrae (HP:0002949) | 3.49592768 |
| 25 | Pustule (HP:0200039) | 3.46005418 |
| 26 | Increased IgE level (HP:0003212) | 3.44911262 |
| 27 | Subacute progressive viral hepatitis (HP:0006572) | 3.43979382 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.43736361 |
| 29 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.43468909 |
| 30 | Hypoplasia of the fovea (HP:0007750) | 3.43468909 |
| 31 | Vaginal fistula (HP:0004320) | 3.41116206 |
| 32 | Periodontitis (HP:0000704) | 3.40834387 |
| 33 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.35670112 |
| 34 | Anomalous pulmonary venous return (HP:0010772) | 3.35023478 |
| 35 | Rhabdomyosarcoma (HP:0002859) | 3.33622582 |
| 36 | Abnormality of the pubic bones (HP:0003172) | 3.30920105 |
| 37 | Recurrent abscess formation (HP:0002722) | 3.28842602 |
| 38 | Bifid tongue (HP:0010297) | 3.27902620 |
| 39 | Gingivitis (HP:0000230) | 3.25516408 |
| 40 | Preauricular pit (HP:0004467) | 3.23318005 |
| 41 | Periauricular skin pits (HP:0100277) | 3.23318005 |
| 42 | Partial duplication of the phalanx of hand (HP:0009999) | 3.16627759 |
| 43 | Neoplasm of striated muscle (HP:0009728) | 3.15712025 |
| 44 | Gingival bleeding (HP:0000225) | 3.13579942 |
| 45 | Hyperventilation (HP:0002883) | 3.07635943 |
| 46 | Abnormal cartilage morphology (HP:0002763) | 3.04953607 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 3.04752410 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.02583241 |
| 49 | Erythema (HP:0010783) | 3.00386458 |
| 50 | Abnormality of the pulmonary veins (HP:0011718) | 2.91884779 |
| 51 | Large earlobe (HP:0009748) | 2.91167908 |
| 52 | Nail dystrophy (HP:0008404) | 2.85006247 |
| 53 | Parakeratosis (HP:0001036) | 2.83736710 |
| 54 | Abnormal blistering of the skin (HP:0008066) | 2.83223550 |
| 55 | Ependymoma (HP:0002888) | 2.82380654 |
| 56 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.80754640 |
| 57 | Short 5th finger (HP:0009237) | 2.78158389 |
| 58 | Amyotrophic lateral sclerosis (HP:0007354) | 2.78071678 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.75519666 |
| 60 | Optic neuritis (HP:0100653) | 2.75519666 |
| 61 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.74860192 |
| 62 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.74537640 |
| 63 | Hypoplastic scapulae (HP:0000882) | 2.74537640 |
| 64 | Tetraplegia (HP:0002445) | 2.71799920 |
| 65 | Tongue fasciculations (HP:0001308) | 2.68197740 |
| 66 | Short humerus (HP:0005792) | 2.67781175 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.64674732 |
| 68 | Abnormality of glycolysis (HP:0004366) | 2.64674732 |
| 69 | Recurrent skin infections (HP:0001581) | 2.64562101 |
| 70 | Ankyloglossia (HP:0010296) | 2.63473110 |
| 71 | Abnormality of the axillary hair (HP:0100134) | 2.62424399 |
| 72 | Abnormality of secondary sexual hair (HP:0009888) | 2.62424399 |
| 73 | Chromsome breakage (HP:0040012) | 2.60695772 |
| 74 | Ectropion (HP:0000656) | 2.58551670 |
| 75 | Abnormality of the salivary glands (HP:0010286) | 2.52885192 |
| 76 | Orchitis (HP:0100796) | 2.52728061 |
| 77 | Embryonal renal neoplasm (HP:0011794) | 2.49627107 |
| 78 | Abnormality of the fovea (HP:0000493) | 2.47749027 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47254907 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47254907 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47254907 |
| 82 | Irregular epiphyses (HP:0010582) | 2.47002504 |
| 83 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.46333452 |
| 84 | Abnormal lung lobation (HP:0002101) | 2.46068536 |
| 85 | Sensory axonal neuropathy (HP:0003390) | 2.43859698 |
| 86 | Postural instability (HP:0002172) | 2.41711011 |
| 87 | Hypoplasia of dental enamel (HP:0006297) | 2.41319704 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.40454077 |
| 89 | Muscle fibrillation (HP:0010546) | 2.40147363 |
| 90 | Cheilitis (HP:0100825) | 2.40043850 |
| 91 | Gangrene (HP:0100758) | 2.39956545 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 2.39741146 |
| 93 | Urticaria (HP:0001025) | 2.38295879 |
| 94 | Recurrent fungal infections (HP:0002841) | 2.35358052 |
| 95 | Skin pits (HP:0100276) | 2.33991868 |
| 96 | Resting tremor (HP:0002322) | 2.33921864 |
| 97 | Abnormality of the corticospinal tract (HP:0002492) | 2.32002299 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.29177690 |
| 99 | Ridged nail (HP:0001807) | 2.28522406 |
| 100 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.28043174 |
| 101 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.26873180 |
| 102 | Hypoplastic labia majora (HP:0000059) | 2.25604640 |
| 103 | Viral hepatitis (HP:0006562) | 2.25508227 |
| 104 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25078605 |
| 105 | Generalized hypotonia (HP:0001290) | 2.24504949 |
| 106 | Lip pit (HP:0100267) | 2.22644777 |
| 107 | Spastic tetraparesis (HP:0001285) | 2.22244469 |
| 108 | Myositis (HP:0100614) | 2.21838921 |
| 109 | Skin ulcer (HP:0200042) | 2.20510027 |
| 110 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.19316419 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.18110344 |
| 112 | Acute myeloid leukemia (HP:0004808) | 2.18101760 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 2.17466240 |
| 114 | Gastrointestinal infarctions (HP:0005244) | 2.17016692 |
| 115 | Alopecia of scalp (HP:0002293) | 2.16396698 |
| 116 | Abnormality of the labia majora (HP:0012881) | 2.13957623 |
| 117 | Spontaneous hematomas (HP:0007420) | 2.13253920 |
| 118 | Flat capital femoral epiphysis (HP:0003370) | 2.12561413 |
| 119 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.12425981 |
| 120 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.11100744 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09819819 |
| 122 | Recurrent viral infections (HP:0004429) | 2.09550124 |
| 123 | Abnormality of the astrocytes (HP:0100707) | 2.09297844 |
| 124 | Astrocytoma (HP:0009592) | 2.09297844 |
| 125 | Wide anterior fontanel (HP:0000260) | 2.08324075 |
| 126 | Fair hair (HP:0002286) | 2.07876893 |
| 127 | Short middle phalanx of the 5th finger (HP:0004220) | 2.07730982 |
| 128 | Hyperhidrosis (HP:0000975) | 2.06161003 |
| 129 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.04895793 |
| 130 | Ulnar bowing (HP:0003031) | 2.03323485 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 2.02549125 |
| 132 | Meckel diverticulum (HP:0002245) | 2.01177036 |
| 133 | Inflammation of the large intestine (HP:0002037) | 2.00466701 |
| 134 | Conjunctival telangiectasia (HP:0000524) | 2.00183973 |
| 135 | Hypoplastic ischia (HP:0003175) | 1.99995782 |
| 136 | Impulsivity (HP:0100710) | 1.99593581 |
| 137 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99468553 |
| 138 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99468553 |
| 139 | Sparse scalp hair (HP:0002209) | 1.99191747 |
| 140 | Vitreoretinal degeneration (HP:0000655) | 1.98754620 |
| 141 | Peritonitis (HP:0002586) | 1.98279682 |
| 142 | Curly hair (HP:0002212) | 1.96898272 |
| 143 | Nasolacrimal duct obstruction (HP:0000579) | 1.95364839 |
| 144 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95267773 |
| 145 | Progressive muscle weakness (HP:0003323) | 1.95010186 |
| 146 | Anhidrosis (HP:0000970) | 1.94672081 |
| 147 | Glossoptosis (HP:0000162) | 1.93335635 |
| 148 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.93106162 |
| 149 | Abnormality of oral frenula (HP:0000190) | 1.92394859 |
| 150 | Prominent occiput (HP:0000269) | 1.92321706 |
| 151 | Pruritus (HP:0000989) | 1.91906353 |
| 152 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91865059 |
| 153 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91040318 |
| 154 | Trismus (HP:0000211) | 1.90206114 |
| 155 | Abnormality of the intervertebral disk (HP:0005108) | 1.88511337 |
| 156 | Testicular atrophy (HP:0000029) | 1.88332595 |
| 157 | Hypokinesia (HP:0002375) | 1.87814267 |
| 158 | Combined immunodeficiency (HP:0005387) | 1.86322994 |
| 159 | Abnormality of the ileum (HP:0001549) | 1.86039951 |
| 160 | Right ventricular cardiomyopathy (HP:0011663) | 1.86039802 |
| 161 | Hypopigmentation of the fundus (HP:0007894) | 1.85877893 |
| 162 | Duplication of thumb phalanx (HP:0009942) | 1.85842795 |
| 163 | Ventricular tachycardia (HP:0004756) | 1.85837470 |
| 164 | Erythroderma (HP:0001019) | 1.85619625 |
| 165 | Laryngomalacia (HP:0001601) | 1.84770489 |
| 166 | Autoimmune hemolytic anemia (HP:0001890) | 1.84085084 |
| 167 | Delayed epiphyseal ossification (HP:0002663) | 1.83687791 |
| 168 | Spinal muscular atrophy (HP:0007269) | 1.83496841 |
| 169 | Difficulty walking (HP:0002355) | 1.83133941 |
| 170 | Small hand (HP:0200055) | 1.82982408 |
| 171 | Abnormality of T cells (HP:0002843) | 1.82915040 |
| 172 | Generalized hypopigmentation of hair (HP:0011358) | 1.82582742 |
| 173 | Absent frontal sinuses (HP:0002688) | 1.82343918 |
| 174 | Difficulty running (HP:0009046) | 1.82045708 |
| 175 | Slow saccadic eye movements (HP:0000514) | 1.81406608 |
| 176 | Arterial thrombosis (HP:0004420) | 1.80536326 |
| 177 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.80355052 |
| 178 | Hand muscle atrophy (HP:0009130) | 1.80091731 |
| 179 | Oral leukoplakia (HP:0002745) | 1.79911270 |
| 180 | Acanthocytosis (HP:0001927) | 1.78370504 |
| 181 | Thyroid carcinoma (HP:0002890) | 1.78336483 |
| 182 | Widely spaced teeth (HP:0000687) | 1.78243311 |
| 183 | Submucous cleft hard palate (HP:0000176) | 1.78025983 |
| 184 | Leukocytosis (HP:0001974) | 1.77156499 |
| 185 | Thyroiditis (HP:0100646) | 1.76908110 |
| 186 | Dehydration (HP:0001944) | 1.74677549 |
| 187 | Poikilocytosis (HP:0004447) | 1.74630195 |
| 188 | Gastrointestinal inflammation (HP:0004386) | 1.74421931 |
| 189 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.74028842 |
| 190 | Mediastinal lymphadenopathy (HP:0100721) | 1.73894191 |
| 191 | Xerostomia (HP:0000217) | 1.73488438 |
| 192 | Aplasia cutis congenita (HP:0001057) | 1.72138733 |
| 193 | Amelogenesis imperfecta (HP:0000705) | 1.71980937 |
| 194 | Abnormality of macrophages (HP:0004311) | 1.71955578 |
| 195 | Palmoplantar keratoderma (HP:0000982) | 1.69646245 |
| 196 | Poikiloderma (HP:0001029) | 1.69265759 |
| 197 | Stomach cancer (HP:0012126) | 1.68866037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.66298483 |
| 2 | GRK5 | 5.74300509 |
| 3 | GRK6 | 4.90913649 |
| 4 | ERN1 | 4.00830617 |
| 5 | GRK1 | 3.97613687 |
| 6 | ADRBK2 | 3.93034002 |
| 7 | CSF1R | 2.85674376 |
| 8 | RIPK4 | 2.53024215 |
| 9 | IRAK4 | 2.48209714 |
| 10 | WNK1 | 2.46001826 |
| 11 | MAP3K2 | 2.41542997 |
| 12 | BLK | 2.36022998 |
| 13 | IKBKE | 2.33439226 |
| 14 | STK10 | 2.21778696 |
| 15 | SGK2 | 2.20047005 |
| 16 | TYRO3 | 2.07895734 |
| 17 | MAPK7 | 2.07009218 |
| 18 | TTK | 2.06420178 |
| 19 | IRAK1 | 2.05915855 |
| 20 | GRK7 | 2.05800027 |
| 21 | ACVR1B | 1.89456145 |
| 22 | TGFBR2 | 1.88602630 |
| 23 | SGK3 | 1.80255794 |
| 24 | MST4 | 1.77820943 |
| 25 | PIK3CG | 1.74554209 |
| 26 | FGR | 1.72240760 |
| 27 | IRAK2 | 1.70477688 |
| 28 | YES1 | 1.69071940 |
| 29 | TAOK3 | 1.58715600 |
| 30 | EPHA2 | 1.55049850 |
| 31 | JAK3 | 1.52890197 |
| 32 | BTK | 1.52120568 |
| 33 | STK24 | 1.46619665 |
| 34 | CAMK1D | 1.45643017 |
| 35 | MAP3K6 | 1.41435606 |
| 36 | MOS | 1.40129195 |
| 37 | CAMK4 | 1.39775484 |
| 38 | PDGFRB | 1.39703068 |
| 39 | MAP2K3 | 1.39113265 |
| 40 | PRKG2 | 1.36175447 |
| 41 | BRD4 | 1.35043280 |
| 42 | SGK494 | 1.32761899 |
| 43 | SGK223 | 1.32761899 |
| 44 | MATK | 1.32015502 |
| 45 | JAK1 | 1.29740785 |
| 46 | MAP3K1 | 1.28995899 |
| 47 | PLK2 | 1.26437108 |
| 48 | ADRBK1 | 1.25390947 |
| 49 | FGFR3 | 1.21113497 |
| 50 | SYK | 1.20777056 |
| 51 | BRSK2 | 1.18847531 |
| 52 | PIM1 | 1.16977078 |
| 53 | CDK6 | 1.16102068 |
| 54 | OBSCN | 1.15949652 |
| 55 | CAMK1G | 1.11254120 |
| 56 | MAP3K10 | 1.10047151 |
| 57 | HCK | 1.09483729 |
| 58 | ALK | 1.09250615 |
| 59 | JAK2 | 1.08545585 |
| 60 | PTK2B | 1.07794192 |
| 61 | TYK2 | 1.06363808 |
| 62 | MST1R | 1.05703319 |
| 63 | MARK2 | 1.04883198 |
| 64 | CDK7 | 1.03717402 |
| 65 | RAF1 | 1.03323153 |
| 66 | TRPM7 | 1.01210233 |
| 67 | TXK | 0.99653369 |
| 68 | TEC | 0.98840497 |
| 69 | FES | 0.97453153 |
| 70 | DYRK3 | 0.96643022 |
| 71 | CAMKK2 | 0.95426099 |
| 72 | EPHB1 | 0.95289468 |
| 73 | KSR2 | 0.93772879 |
| 74 | STK39 | 0.93217597 |
| 75 | IKBKB | 0.92593081 |
| 76 | KSR1 | 0.91230480 |
| 77 | LATS1 | 0.90120799 |
| 78 | EIF2AK2 | 0.89400031 |
| 79 | PAK4 | 0.85250836 |
| 80 | PBK | 0.83688139 |
| 81 | MAP2K4 | 0.81977708 |
| 82 | AKT3 | 0.81620138 |
| 83 | HIPK2 | 0.80435964 |
| 84 | NTRK1 | 0.79967443 |
| 85 | SGK1 | 0.78190286 |
| 86 | MAP3K7 | 0.77888660 |
| 87 | MELK | 0.76511197 |
| 88 | MAP3K5 | 0.75854579 |
| 89 | MARK3 | 0.74955912 |
| 90 | MAP3K14 | 0.73814614 |
| 91 | BMPR2 | 0.73553505 |
| 92 | BCR | 0.72997903 |
| 93 | LCK | 0.71516268 |
| 94 | CHEK2 | 0.71364035 |
| 95 | ZAP70 | 0.70883691 |
| 96 | NLK | 0.70657581 |
| 97 | PLK1 | 0.70126018 |
| 98 | LYN | 0.67741912 |
| 99 | GSK3A | 0.66631874 |
| 100 | STK4 | 0.66233070 |
| 101 | AKT2 | 0.64987090 |
| 102 | MAP3K4 | 0.64081504 |
| 103 | DYRK2 | 0.63880358 |
| 104 | ZAK | 0.63732415 |
| 105 | CSK | 0.59729113 |
| 106 | MAPK12 | 0.59514833 |
| 107 | EPHA3 | 0.58883088 |
| 108 | STK11 | 0.57979322 |
| 109 | PRKCD | 0.55622884 |
| 110 | MAP3K3 | 0.54228990 |
| 111 | IRAK3 | 0.53199763 |
| 112 | IGF1R | 0.53008134 |
| 113 | CHEK1 | 0.52330207 |
| 114 | BMPR1B | 0.52313666 |
| 115 | PRKD3 | 0.51615554 |
| 116 | PRKAA2 | 0.51089968 |
| 117 | CHUK | 0.50366244 |
| 118 | PTK6 | 0.47820533 |
| 119 | NUAK1 | 0.47189852 |
| 120 | PDK2 | 0.43972346 |
| 121 | STK38L | 0.43460286 |
| 122 | SRPK1 | 0.43147545 |
| 123 | NME1 | 0.42510184 |
| 124 | PIK3CA | 0.40885995 |
| 125 | FER | 0.40297180 |
| 126 | TAOK1 | 0.38238630 |
| 127 | RPS6KB1 | 0.36312589 |
| 128 | RET | 0.36009297 |
| 129 | MAPKAPK3 | 0.35674880 |
| 130 | PAK3 | 0.35251375 |
| 131 | PRKCQ | 0.34985671 |
| 132 | FYN | 0.34359648 |
| 133 | ERBB2 | 0.31133491 |
| 134 | PRKCI | 0.30509893 |
| 135 | ICK | 0.29980534 |
| 136 | TESK2 | 0.27892938 |
| 137 | ATM | 0.26852838 |
| 138 | PINK1 | 0.26267904 |
| 139 | RPS6KB2 | 0.26138457 |
| 140 | OXSR1 | 0.26014756 |
| 141 | MAPKAPK2 | 0.25995348 |
| 142 | MAP3K13 | 0.25452669 |
| 143 | MTOR | 0.24167911 |
| 144 | PRKCH | 0.23852708 |
| 145 | STK3 | 0.23716360 |
| 146 | BMX | 0.22192621 |
| 147 | ITK | 0.21033448 |
| 148 | PRKACB | 0.20783276 |
| 149 | DDR2 | 0.19432387 |
| 150 | DYRK1A | 0.19288012 |
| 151 | NEK6 | 0.18236151 |
| 152 | FRK | 0.17726287 |
| 153 | MAPK4 | 0.17679226 |
| 154 | EGFR | 0.17427019 |
| 155 | AURKB | 0.16795403 |
| 156 | PRKACA | 0.16729532 |
| 157 | MAPK1 | 0.16016799 |
| 158 | CDK2 | 0.15954494 |
| 159 | MAP2K6 | 0.15630920 |
| 160 | CDK4 | 0.15060475 |
| 161 | INSR | 0.14535509 |
| 162 | ERBB3 | 0.13830873 |
| 163 | PRKACG | 0.13760440 |
| 164 | CSNK1E | 0.12772100 |
| 165 | MET | 0.12274941 |
| 166 | PKN1 | 0.12154982 |
| 167 | CDK1 | 0.11891535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.75498542 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.84726329 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.71349885 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.10178072 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.95705028 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.80144726 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71359769 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.56697845 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.35914084 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.35196670 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.25797052 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.06910760 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04725069 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.02793391 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94430580 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.88644324 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.83804287 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78711648 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72220509 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69511417 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.67379988 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.63768915 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63161012 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.62390635 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60594727 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56143208 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53510539 |
| 28 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.52710626 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51931195 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.50915815 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50717580 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49043641 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42272758 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42199811 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41617253 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38704593 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36348025 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34182223 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.31219551 |
| 40 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31049000 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30724056 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.30576076 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.29454461 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29317052 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.28826809 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.25957522 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25495068 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24548320 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22968947 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.21850479 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20222003 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19530444 |
| 53 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19089534 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16915312 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13640100 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13469645 |
| 57 | Glioma_Homo sapiens_hsa05214 | 1.13194364 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 1.11437509 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.10824780 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10305821 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10104094 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08670430 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08009761 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06108749 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05299955 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04182925 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02586740 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99634901 |
| 69 | RNA transport_Homo sapiens_hsa03013 | 0.99347000 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96547106 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95937751 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92385176 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.90879692 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88902743 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87853762 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87336166 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86230105 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84543018 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84346669 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.84111069 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82859563 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.80829907 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79557478 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79465329 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77779008 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77462237 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76651534 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76552020 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76379864 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76238174 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73826909 |
| 92 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73433505 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.72593760 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72424864 |
| 95 | Long-term depression_Homo sapiens_hsa04730 | 0.70762657 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70174988 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70140388 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69543584 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69231243 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68905829 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68452607 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67234666 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67118785 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.66392511 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66283086 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66077775 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64796773 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.64624632 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63781536 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63444401 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63240480 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60793624 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.60789380 |
| 114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60667265 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60061526 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58314455 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57418000 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57376009 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56655806 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56289759 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.54289084 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53989838 |
| 123 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53641131 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53069327 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.52953276 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.52745696 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52318362 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51185125 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51085752 |
| 130 | RNA degradation_Homo sapiens_hsa03018 | 0.50870697 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50629061 |
| 132 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49844298 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48560605 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47349284 |
| 135 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45956181 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45317403 |
| 137 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44196318 |
| 138 | Taste transduction_Homo sapiens_hsa04742 | 0.42940883 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42684447 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41301882 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38907617 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38323389 |
| 143 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37522287 |
| 144 | Cell cycle_Homo sapiens_hsa04110 | 0.36006628 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35814632 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34481775 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34208495 |
| 148 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34006505 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33596709 |
| 150 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31732275 |
| 151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31616133 |
| 152 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30760758 |
| 153 | Tight junction_Homo sapiens_hsa04530 | 0.30210101 |
| 154 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30121280 |
| 155 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29783636 |
| 156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29707754 |
| 157 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29100662 |
| 158 | Apoptosis_Homo sapiens_hsa04210 | 0.28808769 |
| 159 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28416171 |
| 160 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28385594 |
| 161 | Peroxisome_Homo sapiens_hsa04146 | 0.26413668 |
| 162 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25860877 |
| 163 | Prion diseases_Homo sapiens_hsa05020 | 0.25649165 |
| 164 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25623796 |
| 165 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23506571 |
| 166 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22950501 |
| 167 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22466839 |
| 168 | Adherens junction_Homo sapiens_hsa04520 | 0.21523235 |
| 169 | Pertussis_Homo sapiens_hsa05133 | 0.19781878 |
| 170 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19430039 |
| 171 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18849826 |
| 172 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18702650 |
| 173 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.18623579 |
| 174 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18277858 |

